ANCA ASSOCIATED SYSTEMIC VASCULITIS
Clinical trials for ANCA ASSOCIATED SYSTEMIC VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new ANCA ASSOCIATED SYSTEMIC VASCULITIS trials appear
Sign up with your email to follow new studies for ANCA ASSOCIATED SYSTEMIC VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Off-the-Shelf cell therapy tested as potential reset for stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing the safety and initial effects of a new type of cell therapy for people with severe autoimmune diseases that haven't responded well to standard treatments. The therapy, called 'universal' CAR-T, uses donated immune cells engineered to target and …
Matched conditions: ANCA ASSOCIATED SYSTEMIC VASCULITIS
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
One-Shot gene therapy trial aims to reset immune system in devastating diseases
Disease control Recruiting nowThis is an early-stage study testing a new, one-time treatment called TI-0032-III injection for people with severe autoimmune diseases that have not improved with standard medications. The treatment uses a single injection of genetic material to reprogram the patient's own immune…
Matched conditions: ANCA ASSOCIATED SYSTEMIC VASCULITIS
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC